Heavy drinking and alcohol use disorder are major public health problems. Practitioners not
specialising in alcohol treatment are often unaware of the guidelines for preventing …

Aims The aims of this study were to (1) estimate the effect of extended‐release naltrexone
compared with placebo on alcohol consumption in patients with alcohol use disorder (AUD) …

Objective: To determine whether extended-release naltrexone (XR-NTX) would improve or
maintain viral suppression (VS) among prisoners or jail detainees with HIV and opioid use …

Background Different methodological choices such as inclusion/exclusion criteria and
analytical models can yield different results and inferences when meta-analyses are …

Abstract Purpose of Review Recent HIV outbreaks have occurred as a result of the current
US opioid epidemic. Providing medications for opioid use disorder (MOUD) with methadone …

Addressing unhealthy alcohol use among people living with HI... : Current Opinion in Infectious
Diseases Addressing unhealthy alcohol use among people living with HIV: recent advances …

Abstract Purpose of Review Behaviors and practices associated with substance use
contribute to lack of HIV virologic suppression and onward transmission. In the USA, many …

Objective: To determine whether extended-release naltrexone (XR-NTX) would improve or
maintain viral suppression (VS) among incarcerated individuals with HIV and alcohol use …

Alcohol use disorder (AUD) presents a significant public health concern given the high
prevalence estimates and numerous deleterious‐associated consequences. The FDA …

We sought to test the efficacy of extended-release naltrexone (XR-NTX) on HIV-related and
drinking outcomes. From April 2011-February 2015, we conducted a 4-site randomized …